Clarice X. Lim
-
- IL-33, ST2, and ILC Pathways 2
-
- Sarcoidosis and Beryllium Toxicity Research 5
- Asthma and respiratory diseases 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 3
- Neonatal Respiratory Health Research 3
-
- Signaling Pathways in Disease 2
-
- Acute Myeloid Leukemia Research 2
-
- Eosinophilic Disorders and Syndromes 2
- Co-authors
- Thomas WeichhartDominique ValeyreAlain CalenderAbderrazzak BentaherYves PachécoSimon G. RoyceMimi L.K. TangStuart Biddle
- Journals
- Immunity (1 paper)American Journal of Respiratory and Critical Care Medicine (1 paper)Journal of Allergy and Clinical Immunology (1 paper)
- Partner nations
- AustriaUnited KingdomGermany
In The Last Decade
Clarice X. Lim
16 papers receiving 332 citations
Peers
Comparison fields: 5 of 73
- Immunology 107
- Physiology 117
- Pulmonary and Respiratory Medicine 102
- Cancer Research 30
- Molecular Biology 114
Countries citing papers authored by Clarice X. Lim
This map shows the geographic impact of Clarice X. Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarice X. Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarice X. Lim more than expected).
Fields of papers citing papers by Clarice X. Lim
This network shows the impact of papers produced by Clarice X. Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarice X. Lim. The network helps show where Clarice X. Lim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Clarice X. Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 10 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 67 | |
| 5 | 2023 | 17 | |
| 6 | 2020 | 16 | |
| 7 | 2020 | 1 | |
| 8 | 2020 | 63 | |
| 9 | 2019 | 9 | |
| 10 | 2016 | 21 | |
| 11 | 2014 | 17 | |
| 12 | 2014 | 29 | |
| 13 | 2012 | 22 | |
| 14 | 2012 | 18 | |
| 15 | 2012 | 31 | |
| 16 | 2011 | 8 |
About Clarice X. Lim
Clarice X. Lim is a scholar working on Physiology, Immunology and Applied Psychology, having authored 16 papers that have together received 334 indexed citations. Recurring topics across this work include Sarcoidosis and Beryllium Toxicity Research (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers), Neonatal Respiratory Health Research (3 papers), Acute Myeloid Leukemia Research (2 papers), Eosinophilic Disorders and Syndromes (2 papers), IL-33, ST2, and ILC Pathways (2 papers), Signaling Pathways in Disease (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Immunology (107 citations), Physiology (117 citations) and Pulmonary and Respiratory Medicine (102 citations). Clarice X. Lim has collaborated with scholars based in Austria, United Kingdom and Germany. Frequent co-authors include Thomas Weichhart, Dominique Valeyre, Alain Calender, Abderrazzak Bentaher, Yves Pachéco, Simon G. Royce, Mimi L.K. Tang, Stuart Biddle, Chrishan S. Samuel and Jan Frič. Their work appears in journals such as Immunity, American Journal of Respiratory and Critical Care Medicine and Journal of Allergy and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.